SciNeuro Pharmaceuticals raises $53 million in equity financing to advance therapies for neurodegenerative diseases, led by LAV and ARCH Venture Partners.
Amount Raised
$53 Million
Round Type
Venture
RockvilleBiotechnologyHealth CareInvestors
Description
SciNeuro Pharmaceuticals has completed $53 million in equity financing to support the advancement of therapies targeting neurodegenerative diseases. The round was led by LAV and ARCH Venture Partners with participation from existing investors. This funding will enhance the company's research capabilities and innovate treatments for CNS disorders. SciNeuro also appointed Hogan Wan as the new Chief Financial Officer to oversee financial management and strategy.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as SciNeuro Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.
- MergeLabs raised $250M (Seed) on January 16, 2026.
- Novabay raised $134M on January 16, 2026.
- Science&Humans raised $7.9M (Series A) on January 15, 2026.
- MARS Bioimaging raised $15M (Series A) on January 14, 2026.
- Os Therapies raised $3.5M on January 14, 2026.
- Vivere Oncotherapies raised $10M (Funding Round) on January 13, 2026.
Who to call at SciNeuro Pharmaceuticals, and when
A new round usually means SciNeuro Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day SciNeuro Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at SciNeuro Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at SciNeuro Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment SciNeuro Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
SciNeuro Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.